|
1) Vakil N, van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006; 101: 1900-20
|
|
|
|
2) Gislason T, Janson C, Vermeire P, et al. Respiratory symptoms and nocturnal gastroesophageal reflux. A population-based study of young adults in three European countries. Chest. 2002; 121: 158-63
|
|
|
|
|
|
3) Nordenstedt H, Nilsson M, Johansson S, et al. The relation between gastroesophageal reflux and respiratory symptoms in a population-based study: the Nord-Trondelag health survey. Chest. 2006; 129: 1051-6
|
|
|
|
|
|
4) El-Serag HB, Sonnenberg A. Comorbid occurrence of laryngeal or pulmonary disease with esophagitis in United States military veterans. Gastroenterology. 1997; 113: 755-60
|
|
|
|
|
|
5) Leggett JJ, Johnston BR, Mills M, et al. Prevalence of gastroesophageal reflux in difficult asthma. Relationship to asthma outcome. Chest. 2005; 127: 1227-31
|
|
|
|
|
|
6) Havemann BD, Henderson CA, El-Serag HB. The association between gastrooesophageal reflux disease and asthma: a systematic review. Gut. 2007; 56: 1654-64
|
|
|
|
|
|
7) Ruigomez A, Rodriguez LA, Wallander MA, et al. Gastroesophageal reflux disease and asthma: a longitudinal study in UK general practice. Chest. 2005; 128: 85-93
|
|
|
|
|
|
8) Zerbib F, Guisset O, Lamouliatte H, et al. Effects of bronchial obstruction on lower esophageal sphincter motility and gastro-esophageal reflux in asthma. Am J Respir Crit Care Med. 2002; 166: 1206-11
|
|
|
|
|
|
9) Crowell MD, Zayat EN, Lacy BE, et al. The effects of an inhaled β2-adrenergic agonist on lower esophageal function: a dose-response study. Chest. 2001; 120: 1184-7
|
|
|
|
|
|
10) Lazenby JP, Guzzo MR, Harding SM, et al. Oral corticosteroids increase esophageal acid contact times in patients with stable asthma. Chest. 2002; 121: 625-34
|
|
|
|
|
|
11) Harding SM. Gastroesophageal reflux, asthma, and mechanisms of interaction. Am J Med. 2001; 111 Suppl 8A: 8S-12S
|
|
|
|
|
|
12) Mansfield LE, Stein MR. Gastroesophageal reflux and asthma: a possible reflex mechanism. Ann Allergy. 1978; 41: 224-6
|
|
|
|
|
|
13) Wright RA, Miller SA, Corsello BF. Acid-induced esophagobronchial-cardiac reflexes in humans. Gastroenterology. 1990; 99: 71-3
|
|
|
|
|
|
14) Harding SM, Schan CA, Guzzo MR, et al. Gastroesophageal reflux-induced broncho-constriction. Is microaspiration a factor？ Chest. 1995; 108: 1220-7
|
|
|
|
|
|
15) Fischer A, Canning BJ, Undem BJ, et al. Evidence for an esophageal origin of VIP-IR and NO synthase-IR nerves innervating the guinea pig trachealis: a retrograde neuronal tracing and immunohistochemical analysis. J Comp Neurol. 1998; 394: 326-34
|
|
|
|
|
|
16) Daoui S, D'Agostino B, Gallelli L, et al. Tachykinins and airway microvascular leakage induced by HCl intra-oesophageal instillation. Eur Respir J. 2002; 20: 268-73
|
|
|
|
|
|
17) Wu D-N, Tanifuji Y, Kobayashi H, et al. Effects of esophageal acid perfusion on airway hyper-responsiveness in patients with bronchial asthma. Chest. 2000; 118: 1553-6
|
|
|
|
|
|
18) Jack CI, Calverley PM, Donnelly RJ, et al. Simultaneous tracheal and oesophageal pH measurements in asthmatic patients with gastro-oesophageal reflux. Thorax. 1995; 50: 201-4
|
|
|
|
|
|
19) Gibson PG, Henry RL, Coughlan JL. Gastro-oesophageal reflux treatment for asthma in adults and children. Cochrane Database Syst Rev. 2003; 2: CD001496
|
|
|
|
|
|
20) Littner MR, Leung FW, Ballard ED 2nd, et al. Effects of 24 weeks of lansoprazole therapy on asthma symptoms, exacerbations, quality of life, and pulmonary function in adult asthmatic patients with acid reflux symptoms. Chest. 2005; 128: 1128-35
|
|
|
|
|
|
21) Kiljander TO, Harding SM, Field SK, et al. Effects of esomeprazole 40 mg twice daily on asthma: a randomised placebo-controlled trial. Am J Respir Crit Care Med. 2006; 173: 1091-7
|
|
|
|
|
|
22) Irwin RS. Chronic cough due to gastroesophageal reflux disease: ACCP evidence-based clinical practice guidelines. Chest. 2006; 129(Suppl. 1): 80S-94S
|
|
|
|
|
|
23) Irwin RS, Richter JE. Gastroesophageal reflux and chronic cough. Am J Gastroenterol. 2000; 95: S9-14
|
|
|
|
|
|
24) Harding SM, Guzzo MR, Richter JE. 24-h esophageal pH testing in asthmatics: respiratory symptom correlation with esophageal acid events. Chest. 1999; 115: 654-9
|
|
|
|
|
|
25) Berg S, Hoffstein V, Gislason T. Acidification of distal esophagus and sleep-related breathing disturbances. Chest. 2004; 125: 2101-6
|
|
|
|
|
|
26) Ing AJ, Ngu MC, Breslin AB. Obstructive sleep apnea and gastroesophageal reflux. Am J Med. 2000; 108 Suppl 4a: 120S-125S
|
|
|
|
|
|
27) Kusano M, Shimoyama Y, Sugimoto S, et al. Development and evaluation of FSSG: frequency scale for the symptoms of GERD. J Gastroenterol. 2004; 39: 888-91
|
|
|
|
|
28) Bortolotti M, Gentilini L, Morselli C, et al. Obstructive sleep apnoea is improved by a prolonged treatment of gastrooesophageal reflux with omeprazole. Dig Liver Dis. 2006; 38: 78-81
|
|
|
|
|
|
29) Salvioli B, Belmonte G, Stanghellini V, et al. Gastro-oesophageal reflux and interstitial lung disease. Dig Liver Dis. 2006; 38: 879-84
|
|
|
|
|
|
30) Ing AJ. Interstitial lung disease and gastro-esophageal reflux. Am J Med. 2001; 111: 41S-4S
|
|
|
|
|
|
31) Tobin RW, Pope CE, Pellegrini CA, et al. Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1998; 158: 1804-8
|
|
|
|
|
|
32) Raghu G, Freudenberger TD, Yang S, et al. High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis. Eur Respir J. 2006; 27: 136-42
|
|
|
|
|
|
33) Niklasson A, Strid H, Simren M, et al. Prevalence of gastrointestinal symptoms in patients with chronic obstructive pulmonary disease. Eur J Gastroenterol Hepatol. 2008; 20: 335-41
|
|
|
|
|
|
34) Garcia Rodriguez LA, Martin-Merino E, Johansson S, et al. Relationship between gastroesophageal reflux disease and COPD in UK primary care. Chest. 2008; 134: 1223-30
|
|
|
|
|
|
35) Mokhlesi B, Morris AL, Huang CF, et al. Increased prevalence of gastroesophageal reflux symptoms in patients with COPD. Chest. 2001; 119: 1043-8
|
|
|
|
|
|
36) Kempainen RR, Savik K, Whelan TP, et al. High Prevalence of Proximal and Distal Gastro-esophageal Reflux Disease in Advanced COPD. Chest. 2007; 131: 1666-71
|
|
|
|
|
|
37) Casanova C, Baudet JS, del Valle Velasco M, et al. Increased gastro-oesophageal reflux disease in patients with severe COPD. Eur Respir J. 2004; 23: 841-5
|
|
|
|
|
|
38) Rascon-Aguilar IE, Pamer M, Wludyka P, et al. Role of gastroesophageal reflux symptoms in exacerbations of COPD. Chest. 2006; 130: 1096-101
|
|
|
|
|
|
39) Terada K, Muro S, Sato S, et al. Impact of gastro-oesophageal reflux disease symptoms on chronic obstructive pulmonary disease exacerbation. Thorax. 2008; 63: 951-5
|
|
|
|
|
|
40) Tsang KW, Lam SK, Lam WK, et al. High seroprevalence of Helicobacter pylori in active bronchiectasis. Am J Respir Crit Care Med. 1998; 158: 1047-51
|
|
|
|
|
|
41) Angrill J, Sanchez N, Agusti C, et al. Does Helicobacter pylori have a pathogenic role in bronchiectasis？ Respir Med. 2006; 100: 1202-7
|
|
|
|
|
|
42) Koh WJ, Lee JH, Kwon YS, et al. Prevalence of gastroesophageal reflux disease in patients with nontuberculous mycobacterial lung disease. Chest. 2007; 131: 1825-30
|
|
|
|
|
|
43) thomson RM, Armstrong JG, Looke DF. Gastroesophageal reflux disease, acid suppression, and Mycobacterium avium complex pulmonary disease. Chest. 2007; 131: 1166-72
|
|
|
|
|
|
44) El-Serag HB, Gilger M, Kuebeler M, et al. Extraesophageal associations of gastroesophageal reflux disease in children without neurologic defects. Gastroenterology. 2001; 121: 1294-9
|
|
|
|
|